CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC
Xueying Yuan(Baylor College of Medicine), Jeffrey M. Rosen(Baylor College of Medicine)
Cited by 0
Related Papers
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
|Nature Communications|2021|59
Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
|Cancer Immunology Research|2023|56
The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states
|BMC Biology|2016|50
Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
|Oncogene|2017|50
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
|Journal of Clinical Investigation|2023|29